People: Atara Biotherapeutics Inc (ATRA.OQ)
Dr.Derrell D. Porter, M.D. has served as our SVP, Head of Commercial since May 2017. From April 2013 to May 2017, he served as Vice President & Head, Commercial Planning at Gilead. From 2007 to 2013, he served in various roles at Abbvie including VP, Oncology Global Pipeline Marketing, Commercial Lead, HIV/Oncology International Marketing and VP/General Manager, Renal Care. Prior to that, he served in various roles at Amgen and was an Engagement Manager at McKinsey & Company. He received a B.S. from University of California, Los Angeles, an M.D. from University of Pennsylvania and a M.B.A from The Wharton School.
|Total Annual Compensation, USD||457,457|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,052,940|
|Fiscal Year Total, USD||1,510,390|